Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05822206 · ClinicalTrials.gov registry record · NA

Trauma Informed Intervention to Support Engagement in HIV Care Among MSM (THRIVE+)

A NA study of HIV/AIDS and Trauma, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT05822206 is a NA study of HIV/AIDS and Trauma that has completed, run by Massachusetts General Hospital. The registered enrollment target is 40 participants, below the 33,180-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05822206, a NA study of HIV/AIDS and Trauma, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

This purpose of this project is to specify and provide an initial test of a 10 session, individual-based cognitive therapy intervention to address symptoms of PTSD and poor engagement in HIV care among men who have sex with men (MSM) with trauma histories

Conditions Studied

Interventions

  • BEHAVIORAL CBT-TSC
  • BEHAVIORAL Life Steps and Sexual Decision-Making

Study Locations (2)

Massachusetts

  • Fenway Community Health - Boston

Ontario

  • Ryerson University - Toronto

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2016-08-03
Est. Completion 2020-03
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT05822206

The ClinicalTrials.gov registry entry for NCT05822206 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 33,180-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV/AIDS appearing as the primary indexed condition, and to 2 interventions - of which CBT-TSC is the first listed.

NCT05822206 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Ontario.

Frequently Asked Questions

What is clinical trial NCT05822206 about?

NCT05822206 is a clinical study titled "Trauma Informed Intervention to Support Engagement in HIV Care Among MSM (THRIVE+)". This purpose of this project is to specify and provide an initial test of a 10 session, individual-based cognitive therapy intervention to address symptoms of PTSD and poor engagement in HIV care among men who have sex with men (MSM) with trauma histories

What is the current status of trial NCT05822206?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2016-08-03. Estimated completion is 2020-03.

What conditions does trial NCT05822206 study?

This clinical trial studies the following conditions: HIV/AIDS, Trauma.

What interventions are being tested in trial NCT05822206?

The interventions under investigation include: CBT-TSC (BEHAVIORAL), Life Steps and Sexual Decision-Making (BEHAVIORAL).

Who is sponsoring clinical trial NCT05822206?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05822206 being conducted?

This trial has 2 study locations across Massachusetts, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV/AIDS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.